Lactobacillus rhamnosus HN001

Lactobacillus rhamnosus HN001 is a clinically-studied probiotic strain that produces bacteriocins and short-chain fatty acids to inhibit pathogenic bacteria growth. This strain modulates immune cell activity through Toll-like receptor signaling pathways in the intestinal mucosa.

Origin & History

Lactobacillus rhamnosus HN001 is a probiotic strain isolated from dairy products. It is recognized for its robust ability to colonize the gut.

Historical & Cultural Context

This strain has been utilized in dairy fermentation processes for centuries, contributing to its widespread use in probiotic supplements.

Health Benefits

- Enhances gut health by promoting a balanced microbiome, reducing harmful bacteria by up to 50% according to studies. This balance aids in nutrient absorption and reduces bloating. - Boosts immune system efficacy by stimulating the production of natural antibodies, enhancing the body's ability to fight infections. - May alleviate symptoms of anxiety by modulating gut-brain axis communication, leading to improved mental well-being. - Reduces the risk of respiratory infections by 30% through enhanced immune response. - Supports skin health by reducing inflammation, leading to clearer skin. - Improves lactose digestion, making dairy consumption more comfortable. - Aids in weight management by influencing metabolism and reducing fat storage.

How It Works

Lactobacillus rhamnosus HN001 produces antimicrobial bacteriocins and lactic acid that create an acidic environment inhibiting pathogenic bacteria like E. coli and Salmonella. The strain activates dendritic cells and stimulates cytokine production through interaction with intestinal epithelial Toll-like receptors 2 and 9. Its metabolites including butyrate and propionate strengthen tight junction proteins and enhance intestinal barrier function.

Scientific Research

Studies show its positive effects on gut and mental health, but further research is necessary to fully understand its benefits.

Clinical Summary

Multiple randomized controlled trials involving 200-400 participants demonstrate HN001's ability to reduce pathogenic bacteria populations by up to 50% within 4-6 weeks of supplementation. Clinical studies show significant increases in secretory IgA antibody levels and enhanced natural killer cell activity in healthy adults taking 1-10 billion CFU daily. Evidence from pregnancy studies indicates improved maternal immune markers and reduced infant eczema rates, though more large-scale trials are needed to confirm all immune benefits.

Nutritional Profile

- Contains beneficial probiotics. - Supports mental and physical health. - Enhances gut microbiota.

Preparation & Dosage

Standard dosage ranges from 1 to 10 billion CFU per day. Consult a healthcare provider before use.

Synergy & Pairings

Bifidobacterium animalis subsp. lactis Bi-07, Streptococcus thermophilus TH-4, Leuconostoc mesenteroides

Safety & Interactions

Lactobacillus rhamnosus HN001 is generally well-tolerated with mild gastrointestinal symptoms like bloating or gas occurring in fewer than 5% of users during the first week. The strain may theoretically reduce effectiveness of certain antibiotics, particularly broad-spectrum types, so timing separation is recommended. Immunocompromised individuals should consult healthcare providers before use due to rare reports of probiotic bacteremia. Safety during pregnancy appears favorable based on clinical trials, but breastfeeding women should seek medical guidance.